https://www.taxtmi.com/acts?id=19513 Advance authorisation for pharmaceutical products manufactured through a Non Infringing (NI) process requires maintaining Appendix 4I register recording authorisation details, inputs (names and quantities), exported product and quantities, inputs actually consumed, balanced inputs and proportional reductions where partial or nil imports occurred; post export replenishment and documentary evidence must be furnished. A Central Excise Certificate, signed by an official not below Superintendent, must verify production records and state per unit input consumption. A solvent allowance policy ties permissible solvent quantities to ANDA/DMF requirements, subject to Central Excise verification. en-us Wed, 15 Apr 2015 10:20:42 +0530 Thu, 14 Dec 2017 16:30:19 +0530 TaxTMI RSS Generator https://www.taxtmi.com/acts?id=19513 Advance authorisation for pharmaceutical products manufactured through a Non Infringing (NI) process requires maintaining Appendix 4I register recording authorisation details, inputs (names and quantities), exported product and quantities, inputs actually consumed, balanced inputs and proportional reductions where partial or nil imports occurred; post export replenishment and documentary evidence must be furnished. A Central Excise Certificate, signed by an official not below Superintendent, must verify production records and state per unit input consumption. A solvent allowance policy ties permissible solvent quantities to ANDA/DMF requirements, subject to Central Excise verification. Act-Rules DGFT Wed, 15 Apr 2015 10:20:42 +0530 https://www.taxtmi.com/acts?id=19513